Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦

In @JExpMed, @ReboldiLab @BucciVanni et al. reveal that #microbiome-driven tuft cells’ hyperplasia in the colon helps defend against Clostridioides difficile infection, providing a pathway thru which host & microbial interactions protect against pathogens hubs.la/Q02ZBWxx0

@mraffatellu Totally agree Manuela!! Thank you!!!

@BucciVanni How many Italians are so lucky to have their own olive trees and make their own organic extra virgin olive oil! I bring liters back with me each time. So special. Enjoy!

Olive picking at home…#bluezone

@pippograd Thank you Pippo! Solo di passaggio due giorni purtroppo… un abbraccione

@BucciVanni Posto top! 😍 Bentornato Vanni 💜

@pippograd Sono di Sant’Ilario a Colombaia… grande Pippo!

@BucciVanni Ma sono toscane o made in US? 🤔😄

The Vedanta team is very excited to share our latest findings coming out of our successful VE303 Ph2 study in CDI. #IDWeek2024

Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes businesswire.com/news/home/2024…

@lingchongyou Amazing work!

1. Excited to share our new study, just published in Cell. First off, link to paper: cell.com/cell/fulltext/…

Just came back from Memorial Day at Harvard Bookstore. Will have some fun reads for the next couple of months…

Looking to learn more about the #microbiome? Come along to #FOGBoston and hear from @BucciVanni (Associate Professor, Microbiology and Physiological Systems, @UMassChan). Register now: hubs.la/Q02sq1c70

TIME's list of the 100 Most Influential People in the world is out. I'm honored, delighted, and grateful to be a part of this incredible group #TIME100 🙏🏼🙏🏼🙏🏼 @TIME time.com/6964230/akiko-…

Playing #Juventus is always a difficult game for @TorinoFC_1906 who don't have Juve's money, but the Torino people always have hope - In bocca al Lupo al Toro Sabado - #ForzaToro Sempre...

Early-onset colorectal cancer is expected to become the leading cause of #cancer death in ages 20 to 49 in the U.S. by 2030. Research is urgently needed to better detect and treat patients, argues this #SciencePerspective: scim.ag/6pk #ColorectalCancerAwarenessMonth

Drug-resistant tuberculosis: a persistent global health concern nature.com/articles/s4157… Ahead of #WorldTBDay this weekend, Pai (@paimadhu) & co review the global landscape of drug-resistant TB, its causes, risk factors, impact, latest diagnostics, treatments, and more.

@mitchell_sysbio @MarianaNoto @ScienceMagazine Amazing work Amir and Mariana!!!!

Why are some non-antibiotic drugs toxic to bacteria 💊☠️🦠? Do they work like standard #antibiotics (ABX)? Our latest work by @MarianaNoto published @ScienceMagazine addresses this fundamental question (1/n) science.org/doi/10.1126/sc…

Microbiota time! 🦠 #PreprintHub2 w/ Catherine Shelton @Mari_Byndloss and @AlisaIakupova will discuss a #preprint on how microbial FA metabolism expands tuft cells to protect tissues homeostasis during C. difficile infection @BucciVanni @ReboldiLab 🐭👇 biorxiv.org/content/10.110…

Microbiota encoded fatty-acid metabolism expands tuft cells to protect tissues homeostasis during Clostridioides difficile infection in the large intestine biorxiv.org/content/10.110… new preprint from the lab. Finalizing experiments for full paper reviews.. @ReboldiLab

Commensal bacteria in the gut #microbiome display surprising resilience to #antibiotics, evolve resistance mutations, and reestablish a healthy biome after treatment, shows a 20-month long study of patients with #tuberculosis. @BucciVanni @MichaelGlickma1 scim.ag/5A0

Our new paper is out! Another great collaboration with @MichaelGlickma1 Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption | Science Translational Medicine science.org/doi/10.1126/sc…